3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
5
Phase 1/2
2
Phase NA
1
Phase 3
1
Phase 2/3
1
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
5
Neoplasms
4
Recurrence
3
Prostatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Respiratory Aspiration
2
Myelodysplastic Syndromes
2
Liver Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Postoperative Complications
1
Postoperative Cognitive Complications
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma, B-Cell
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Immunologic Deficiency Syndromes
1
Hormone Refractory Prostate Cancer
1
Head and Neck Neoplasms
1
HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy
1
Delirium
1
Interventions
Colonoscopy
44
Standard of Care
28
Early Intervention, Educational
23
Methods
22
Blood Specimen Collection
21
Exercise
20
Educational Status
19
Interviews as Topic
13
Surveys and Questionnaires
12
Patient Navigation
12
Counseling
12
Practice Guidelines as Topic
11
Endoscopic Mucosal Resection
10
Drug Therapy
10
Oxaliplatin
9
Irinotecan
8
Fluorouracil
8
Surgical Procedures, Operative
7
Preoperative Exercise
7
Lidocaine
7
Bevacizumab
7
Therapeutics
6
Resistance Training
6
Occult Blood
6
Narrow Band Imaging
6
Mass Screening
6
Leucovorin
6
Diet
6
Decision Support Techniques
6
Control Groups
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Colorectal Neoplasms
×
Injections
×
Clear all
NCT05250791
2023-06-09
FLICOR
Imperial College London
Phase NA
Unknown
50 enrolled